A Kentucky Fried Chicken (KFC) restaurant is pictured in Tokyo, Japan, December 14, 2021. REUTERS/Kim Kyung-Hoon


Kirkland & Ellis and Nishimura & Asahi are advising Crispy Holdings, a fund wholly owned by Carlyle Group, on a 135-billion-yen ($863 million) tender offer for shares of Tokyo-listed KFC Holdings Japan.

Mori Hamada & Matsumoto is representing KFC Japan, while Nagashima Ohno & Tsunematsu is counseling Mitsubishi Corp, the single largest shareholder in the fried-chicken seller with a 35 percent stake.

This sale comes as a part of Mitsubishi’s restructuring of its business portfolio amid a fast-evolving food and restaurant services trend in Japan, where aging population and health-consciousness have been changing demand from consumers, Mitsubishi said in a statement.

The Kirkland team is led by partners Jesse Sheley and Jeffery Norman, with support from partners Pierre-Luc Arsenault, Maurice Conway and Min Wang.

The Nishimura team is headed by partners Keitaro Hamada, Toshiyuki Nonaka, Hiroko Jimbo and Mayuko Nakamura.

Partners Koji Toshima and Takeshi Fukuda lead the Mori Hamada team.

The Nagashima Ohno team is headed by partners Sho Awaya and Yu Tamura.



Related Articles

Top CAM dealmaker rocks market with move to Khaitan

by Nimitt Dixit |

Top Indian dealmaker Shishir Vayttaden has left the equity partnership at Cyril Amarchand Mangaldas to join Khaitan & Co, along with two other partners in his team, K. Aishwarya and Aditi Singhvi.

White & Case guides $380mln U.S.-Japan LNG deal

by Nimitt Dixit |

Global law firm White & Case has advised Japan Petroleum Exploration Co. (JAPEX) on the acquisition through its U.S. subsidiary of an equity interest in Gulf Coast LNG Holdings, which owns an interest in the Freeport LNG project in Texas, from JERA Americas for approximately $380 million.

Reed Smith, Freshfields, Kirkland on Henlius’ $691 mln take-private deal

Freshfields Bruckhaus Deringer is representing Hong Kong-listed biotech company Henlius on its $691 million take-private deal offer from Shanghai Fosun New Medicine Research Company, which is being advised by Reed Smith.